Schizophrenia.com
Effects of Long-Term Deutetrabenazine Treatment in Patients with Tardive Dyskinesia and Underlying Psychiatric or Mood Disorders
News
everhopeful
April 28, 2022, 11:47am
1
Related topics
Topic
Replies
Views
Activity
FDA Approves Deutetrabenazine for Treatment of Tardive Dyskinesia
News
0
686
August 31, 2017
Antipsychotic Dose Reduction Increases Mental Health-Related and All-Cause Hospitalizations
News
0
359
October 12, 2018
Unique and overlapping mechanisms of valbenazine, deutetrabenazine, and vitamin E for tardive dyskinesia
News
1
39
April 24, 2025
Deep Brain Stimulation in the Treatment of Tardive Dyskinesia - PubMed
News
0
271
March 11, 2023
Efficacy and acceptability of pharmacological interventions for tardive dyskinesia in people with schizophrenia or mood disorders: a systematic review and network meta-analysis
News
1
27
December 20, 2024
